Posted by Michael Wonder on 08 Dec 2020
CDER focuses on novel drug development tools to help speed creation of new therapies
7 December 2020 - There are many novel drug development tools that incorporate the latest advances in science and technology but may not have a clear path forward for use in drug development.
To encourage use of these novel tools, the FDA is launching the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.
This program will create a “home” for new technologies aimed to support, streamline and potentially speed up development of drugs and biologics.
